List view / Grid view
The acquisition of Tmunity Therapeutics supports Kite’s plans to develop…
The acquisition of Tmunity Therapeutics supports Kite’s plans to develop next generation CAR T-cell therapies for cancer.
Researchers demonstrated promising early results for a personalised CAR T-cell…
Researchers demonstrated promising early results for a personalised CAR T-cell therapy, which facilitated remission for lupus patients treated with the anti-CD19 treatment.
The first US in-human trial of CRISPR-Cas9-edited T cells has…
The first US in-human trial of CRISPR-Cas9-edited T cells has concluded with no ill effects and showed that nine months later the infused cells were still active against cancer.
Immune-cell based therapies opening a new frontier for cancer treatment…
Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects...
